Nippon India Pharma Fund - Direct (G) vs Sundaram Mid Cap Fund - Direct (G)

Nippon India Pharma Fund - Direct (G) vs Sundaram Mid Cap Fund - Direct (G)

stock1

Nippon India Pharma Fund - Direct (G)

7.4%

stock2

Sundaram Mid Cap Fund - Direct (G)

9.63%

Loading chart...

About Fund

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Standard Chartered Bank HDFC Bank

Computer Age Management Services (P) Ltd.

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

Very High Risk

100

14026.07

1.24

1647.1335

January 1, 2013

0

14.01 %

19.35 %

7.4 %

18.81 %

21.49 %

9.63 %

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

S Bharath

B.Com, MBA, ICWA

He has experience over 20 years in research and he is the dedicated fund manager for overseas securities. He joined Sundaram AMC in 2004.

S Krishnakumar

BE, PGDBA (Financial & Portfolio Management)

He has over 18 Years of total experience in which 7 years related to the Equity Markets. He was a Vice President (Research) at Anush Shares & Securities.

Get your FAQs right